0 Комментарии
0 Поделились
295 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Herpes Simplex Virus (HSV) Vaccines Market Reaching USD 1,360 Million by 2034According to a new report from Intel Market Research, the global Herpes Simplex Virus (HSV) Vaccines market was valued at USD 865 million in 2024 and is projected to reach USD 1,360 million by 2034, growing at a robust CAGR of 6.8% during the forecast period (2025–2034). This growth is driven by the increasing global prevalence of HSV infections, rising awareness about sexually...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
US Human Rabies Immunoglobulin Market Trends, Competitive Analysis and Future OpportunitiesThe United States represents a significant market for human rabies immunoglobulin due to its well-established healthcare infrastructure, widespread availability of post-exposure prophylaxis treatments, and strong public health surveillance systems. Although human rabies cases remain relatively rare in the country, healthcare providers maintain strict protocols for managing potential rabies...0 Комментарии 0 Поделились 962 Просмотры 0 предпросмотр